产品展示

产品展示

Current: Home > Products > Aptamer synthesis

ContactContact Us

Suzhou Biosyntech Co., Ltd

Contact:Manager Chen

TEL:15720786205

E-mail:order@bsyntech.com

Contact:Manager Kong

TEL:18014868899 / 13773114886

E-mail:kongsd@bsyntech.com

Aptamer synthesis

Aptamer synthesis

Aptamer is a short strand of DNA or RNA, which can be folded to form a unique three-dimensional structure and bind specifically to the target, thus regulating the function of the protein. They have affinity and specificity, and can reach levels similar to monoclonal antibodies. At the same time, they are not easily affected by environmental factors such as pH and temperature, and can be screened in vitro without immunogenicity or toxicity (the mechanism of action is shown in the figure below).

Aptamer mechanism of action

There are currently two Aptamer drugs on the market, as shown in the table below. Biosyntech can provide chemically synthesized Aptamers with good stability and high purity.

Trade Name

Drug Name

Company

Target Spot

Indication

chemical modification

Time to Market

Macugen

pegaptanib

Pfizer

VEGF-165

Neovascular age-related macular degeneration

PEG modification

2004(Delisted)

Lzervay

avacincaptad pegol

Iveric Bio

C5

geographic atrophy

caused by age-related macular degeneration


2023



Next:crRNA&tracrRNA synthesis2024-07-27
  • menu

Wechat

Wechat

Address:Room 503, Building 1, No. 515 Xincheng South Road, Kunshan City, Jiangsu Province

Phone:+86-0512-53980886

Email:order@bsyntech.com

Copyright © Suzhou Biosyntech Co., Ltd All rights reserved record number:Su ICP No. 2024107123-1 Mainly engaged insiRNA,Oligonucleotide,Small nucleic acids, Welcome to inquire!
Technical Support: Suzhou Biosyntech Disclaimers